← Leaderboards
Henry Li
Kylin Therapeutics, Inc.
$731,779
Attributed
$1,795,336
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $434.6K · FY2009–14$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,795,336 · 2
By mechanism
U01$1,595,336 · 1
R43$200,000 · 1
Top collaborators
- Peixuan Guo6 shared
- John Joseph Rossi6 shared
Others in their field
Top investigators on “Targeted Delivery”
- Wafaa M. El-Sadr · Columbia University Health Sciences$104,068,526
- Myron S Cohen · Family Health International$101,800,876
- Walter John Curran · Thomas Jefferson University$68,506,733
- Elaine D. Eaker · Eaker Epidemiology Enterprises, Llc$63,680,802
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$58,495,626
- Sundeep Khosla · Mayo Clinic Rochester$49,839,381
Research focus
Targeted DeliveryIn VivoMotorStructureNanotechnologyAptamerGene SilencingMalignant NeoplasmsNanoparticleSmall Interfering RnaAnimalsPharmacologic SubstanceDesignDrug KineticsAnimal ModelCatalytic RnaImageAffinityCancer TherapyCancer CellClinical ApplicationBiomedical EngineeringHealthcareBiological Models
Grant awards (7)
RNA Nanotechnology in Cancer Therapy$312,438
U01 · FY2014 · CA
RNA Nanotechnology in Cancer Therapy$65,142
U01 · FY2014 · CA
RNA Nanotechnology in Cancer Therapy$374,523
U01 · FY2013 · CA
RNA Nanotechnology in Cancer Therapy$408,591
U01 · FY2012 · CA
RNA Nanotechnology in Cancer Therapy$356,186
U01 · FY2011 · CA
RNA Nanotechnology in Cancer Therapy$78,456
U01 · FY2011 · CA
pRNA Nanoparticles for Therapeutic Use$200,000
R43 · FY2009 · GM · contact PI